Stephen Potter

Stephen has more than 15 years of experience as a senior biotechnology industry executive. Prior to AGTC, he was most recently employed by NeoStem, Inc., where Stephen served as Executive Vice President and a member of the Board of Directors. He was Senior Vice President of Operations and Corporate Development for Osiris Therapeutics, Inc., where he was part of the senior leadership team that achieved approval of the first-ever stem cell drug therapy, Prochymal®. Stephen was also responsible for the launch and overall management of the Bio-Surgery business unit as well as operational oversight for multiple functional areas. Prior to Osiris, Stephen served as Senior Vice President of Corporate and Business Development at Genzyme Corporation and as Vice President of Corporate and Business Development.